Last reviewed · How we verify
Red blood cells unit age 14 days or less
Red blood cells unit age 14 days or less is a Biologic drug developed by Abdelrady S Ibrahim, MD. It is currently in Phase 2 development.
At a glance
| Generic name | Red blood cells unit age 14 days or less |
|---|---|
| Sponsor | Abdelrady S Ibrahim, MD |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- The Effect of Red Blood Cells Storage Duration on Biochemical Changes in Pediatric Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Red blood cells unit age 14 days or less CI brief — competitive landscape report
- Red blood cells unit age 14 days or less updates RSS · CI watch RSS
- Abdelrady S Ibrahim, MD portfolio CI
Frequently asked questions about Red blood cells unit age 14 days or less
What is Red blood cells unit age 14 days or less?
Red blood cells unit age 14 days or less is a Biologic drug developed by Abdelrady S Ibrahim, MD.
Who makes Red blood cells unit age 14 days or less?
Red blood cells unit age 14 days or less is developed by Abdelrady S Ibrahim, MD (see full Abdelrady S Ibrahim, MD pipeline at /company/abdelrady-s-ibrahim-md).
What development phase is Red blood cells unit age 14 days or less in?
Red blood cells unit age 14 days or less is in Phase 2.